论文部分内容阅读
目的观察小剂量米索前列醇及缩宫素用于足月胎膜早破引产的临床疗效。方法将2012年5月至2013年5月本院接收自然分娩的2000例产妇中足月胎膜早破并进行成功引产的350例作为研究对象。根据不同引产方法将其分为观察组160例与对照组190例。观察组产妇引产中应用小剂量米索前列醇,对照组产妇引产则应用缩宫素。结果观察组引产成功率为86.2%,产后出血量为(125.0±74.3)ml,明显优于对照组,差异有统计学意义(P<0.05)。结论小剂量米索前列醇对足月胎膜早破引产具有积极的意义,在妇产科临床方面值得推广。
Objective To observe the clinical efficacy of low-dose misoprostol and oxytocin for term premature rupture of membranes induced by labor. Methods From May 2012 to May 2013, 350 pregnant women with full-term premature rupture of membranes who received natural childbirth in our hospital received 350 cases of successful induction of labor. According to different induction of labor, it was divided into observation group 160 cases and control group 190 cases. Observation group maternal induction of labor in the application of low-dose misoprostol, the control group maternal induction of labor is the use of oxytocin. Results The success rate of induction of labor in the observation group was 86.2%, and the amount of postpartum hemorrhage was (125.0 ± 74.3) ml, which was significantly better than that of the control group. The difference was statistically significant (P <0.05). Conclusion Low-dose misoprostol has a positive effect on term premature rupture of membranes and is worthy of promotion in the clinical aspects of obstetrics and gynecology.